BACKGROUND: This study was carried out to identify racial/ethnic differences in predictors of prostate-specific antigen (PSA) screening in a group of prostate cancer patients. METHODS: In this cross-sectional study, a total of 935 prostate cancer patients were recruited from the Texas Medical Center, Houston, between 1996 and 2004. It included 372 Caucasians, 346 African Americans and 217 Hispanics. A structured questionnaire was used to collect data on socio-demographic and life-style related variables, and self-reported PSA screening history through personal interview. RESULTS: African American (54.4%) and Hispanic patients (42.3%) were significantly less likely (p = 0.004 and p < 0.001, respectively) to report having had PSA screening than Caucasian patients (63.2%). Only annual check-up was found to be a significant predictor of PSA screening in Hispanics. Among Caucasians, education and annual check-up were significant predictors of PSA screening; whereas in African Americans, education, annual check-up, marital status and BMI were significant predictors of PSA screening. CONCLUSIONS: The rates of PSAscreening and its predictors varied by race/ethnicity in this tri-ethnic population. Health-education programs and culturally appropriate educational outreach efforts, especially targeted for high-risk groups, are needed to reduce these disparities.

University of Texas Medical Branch at Galveston Texas USA

Zobrazit více v PubMed

Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010 Sep–Oct;60(5):277–300. PubMed

Robbins AS, Whittemore AS, Thom DH. Differences in socioeconomic status and survival among white and black men with prostate cancer. Am J Epidemiol. 2000 Feb 15;151(4):409–416. PubMed

Powell IJ, Schwartz K, Hussain M. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system. Urology. 1995 Dec;46(6):825–830. PubMed

Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002 Dec 3;137(11):917–929. PubMed

Fowke JH, Schlundt D, Signorello LB, Ukoli FA, Blot WJ. Prostate cancor screening between low-income African-American and Caucasian men. Urol Oncol. 2005 Sep–Oct;23(5):333–340. PubMed

National Institutes of Health. [cited 2009 April 6];Addressing health disparities: the NIH Program of Action [Internet] Available from: http://healthdisparities.nih.gov/whatare.html.

Gilligan T, Wang PS, Levin R, Kantoff PW, Avorn J. Racial differences in screening for prostate cancer in the elderly. Arch Intern Med. 2004 Sep 27;164(17):1858–1864. PubMed

Spitz MR, Strom SS, Yamamura Y, Troncoso P, Babaian RJ, Scardino PT, et al. Epidemiologic determinants of clinically relevant prostate cancer. Int J Cancer. 2000 May 20;89(3):259–264. PubMed

Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA. 2003 Mar 19;289(11):1414–1420. PubMed

Steele CB, Miller DS, Maylahn C, Uhler RJ, Baker CT. Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health. 2000 Oct;90(10):1595–1600. PubMed PMC

Weinrich SP. Prostate cancer screening in high-risk men: African American Hereditary Prostate Cancer Study Network. Cancer. 2006 Feb 15;106(4):796–803. PubMed

Wolf AM, Nasser JF, Wolf AM, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med. 1996 Jun 24;156(12):1333–1336. PubMed

Chan EC, Haynes MC, O’Donnell FT, Bachino C, Vernon SW. Cultural sensitivity and informed decision making about prostate cancer screening. J Community Health. 2003 Dec;28(6):393–405. PubMed

Lu-Yao G, Stukel TA, Yao SL. Prostate-specific antigen screening in elderly men. J Natl Cancer Inst. 2003 Dec 3;95(23):1792–1797. PubMed

Eisen SA, Waterman B, Skinner CS, Scherrer JF, Romeis JC, Bucholz K, et al. Sociodemographic and health status characteristics with prostate cancer screening in a national cohort of middle-aged male veterans. Urology. 1999 Mar;53(3):516–522. PubMed

Steenland K, Rodriguez C, Mondul A, Calle EE, Thun M. Prostate cancer incidence and survival in relation to education (United States) Cancer Cause Control. 2004 Nov;15(9):939–945. PubMed

Finney Rutten LJ, Meissner HI, Breen N, Vernon SW, Rimer BK. Factors associated with men’s use of prostate-specific antigen screening: evidence from Health Information National Trends Survey. Prev Med. 2005 Apr;40(4):461–468. PubMed

Moran WP, Cohen SJ, Preisser JS, Wofford JL, Shelton BJ, McClatchey MW. Factors influencing use of the prostate-specific antigen screening test in primary care. Am J Manag Care. 2000 Mar;6(3):315–324. PubMed

Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001 Nov 21;93(22):1704–1713. PubMed

Scales CD, Jr, Antonelli J, Curtis LH, Schulman KA, Moul JW. Prostate-specific antigen screening among young men in the United States. Cancer. 2008 Sep 15;113(6):1315–1323. PubMed

Fowke JH, Signorello LB, Underwood W, 3rd, Ukoli FA, Blot WJ. Obesity and prostate cancer screening among African-American and Caucasian men. Prostate. 2006 Sep 15;66(13):1371–1380. PubMed

Scales CD, Jr, Curtis LH, Norris RD, Schulman KA, Dahm P, Moul JW. Relationship between body mass index and prostate cancer screening in the United States. J Urol. 2007 Feb;177(2):493–498. PubMed

Wadden TA, Stunkard AJ. Social and psychological consequences of obesity. Ann Intern Med. 1985 Dec;103(6 ( Pt 2)):1062–1067. PubMed

Allan JD, Mayo K, Michel Y. Body size values of white and black women. Res Nurs Health. 1993 Oct;16(5):323–333. PubMed

Amy NK, Aalborg A, Lyons P, Keranen L. Barriers to routine gynecological cancer screening for White and African-American obese women. Int J Obes (Lond) 2006 Jan;30(1):147–155. PubMed

Nayeri K, Pitaro G, Feldman JG. Marital status and stage at diagnosis in cancer. N Y State J Med. 1992 Jan;92(1):8–11. PubMed

Bratt O. Hereditary prostate cancer: clinical aspects. J Urol. 2002 Sep;168(3):906–913. PubMed

Fernández-Esquer ME, Espinoza P, Ramirez AG, McAlister AL. Repeated Pap smear screening among Mexican-American women. Health Educ Res. 2003 Aug;18(4):477–487. PubMed